Our Consultants:

David L. Page, M.D.

Dr. David L. Page has served as Professor of Pathology at Vanderbilt University Medical Center since 1978. He also served as Director of Anatomic Pathology from 1977 to 1999. He became Professor of Preventive Medicine (Epidemiology) in 1993.

Dr. Page is known for his studies of breast cancer and premalignant disease. Since 1989 he has been chairman of the Breast Pathology Committee of the Eastern Cooperative Oncology group and serves as consultant to studies at several centers in the U.S. and Canada. He has been a member of the Epidemiology and Disease Control Study section (National Institutes of Health), Council of Arthur Purdy Stout Society of Surgical Pathologists and Association of Directors of Anatomic and Surgical Pathology, and the Anatomic Pathology Council of the American Society of Clinical Pathologists. He serves on editorial boards of Human Pathology; American Journal Clinical Pathology; Cancer Epidemiology, Biomarkers and Prevention; Breast Cancer Research and Treatment; Journal National Cancer Institute; and The Breast (Edinburgh).

He is senior author of the text, Diagnostic Histopathology of the Breast, a widely used text of breast pathology and associate editor of The Breast: A Comprehensive Textbook (Bland and Copeland, Editors), which is multidisciplinary.

Roy A. Jensen, M.D. - Director, Kansas Masonic Cancer Research Institute

Associate Professor of Pathology; Associate Professor of Cell Biology; Manager, Human Tissue Acquisition and Pathology Shared Resource

Roy A. Jensen, M.D. graduated from Vanderbilt University School of Medicine in 1984, and remained there to complete a residency in Anatomic Pathology and a Surgical Pathology fellowship with Dr. David L. Page. Following his clinical training, he accepted a research fellowship at the National Cancer Institute in the laboratory of Dr. Stuart Aaronson.

He returned to Vanderbilt in 1991 and was appointed an Assistant Professor in the departments of Pathology and Cell Biology. In 1996 Dr. Jensen was promoted to Associate Professor of Pathology and Cell Biology and was appointed as an investigator in the Vanderbilt Cancer Center.

Dr. Jensen is a member of several scientific and professional societies including the American Association for the Advancement of Science, the American Society for Cell Biology, the American Society for Investigative Pathology, and the United States and Canadian Academy of Pathology. He currently has over 90 scientific publications and has lectured widely on the clinical and molecular aspects of breast cancer pathology.

Dr. Jensen's research interests are focused on understanding the function of BRCA1 and BRCA2 and their role in breast neoplasia; and in the characterization of premalignant breast disease both at the morphologic and molecular levels.

Dr. Jensen was appointed the Cancer Center Director and the William R. Jewell, M.D. Distinguished University Professor of Pathology at the University of Kansas July 1, 2004.

Consults specifically addressed to Dr. Jensen should be sent to the address listed for the University of Kansas site.

Jean F. Simpson, M.D.

Dr. Jean F. Simpson is Associate Professor of Pathology at Vanderbilt University Medical Center. She completed residency training at Vanderbilt, and served as surgical pathology fellow with Dr. David L. Page. After practicing pathology for six years at the City of Hope National Medical Center in Duarte, California, she returned to Vanderbilt in 1997, and became Director of Anatomic Pathology in 1999.

Dr. Simpson serves on the Southwest Oncology Group Breast Pathology Committee, and is a member of the editorial board of Human Pathology.

Research interests include molecular and morphologic characterization of ductal carcinoma in situ, and prognostic factors for breast cancer.

Melinda E. Sanders, M. D.

Melinda E. Sanders, M.D. is an Assistant Professor of Pathology and a Subspecialty Consultant in the Pathology of Breast Disease at the Vanderbilt University Medical Center. She received her M.D. degree from Jefferson Medical College in Philadelphia, PA in 1995. She subsequently completed her residency training in Anatomic Pathology and Clinical Pathology as well as a Surgical Pathology Fellowship at the University of Pennsylvania in Philadelphia, PA ending July 2000. Following completion of a subspecialty fellowship in Breast pathology under Dr. David Page. Dr. Sanders joined the Surgical Pathology Staff and Breast Consultation Service at Vanderbilt. Dr. Sanders also has substantial experience in translation research and maintains an active research program here at Vanderbilt. Her principal projects involve 1) Protein and gene expression profiling of breast cancer, and 2) Influence of polymorphisms in components of the Transforming Growth Factor Beta pathway on breast cancer risk.

Bernadette McLaren, M.D.

Dr. Bernadette McLaren is a Clinical Instructor in the Department of Pathology at Vanderbilt University Medical Center. She received her M.D. degree from Baylor College of Medicine in Houston, TX in 1995. She started her residency training at University Hospital in Cincinnati, OH, spent three years in residency at Louisiana State University, Shreveport, LA, and finished at Vanderbilt in 2004 after completing a breast fellowship with Dr. Page. She also served as the Pathology fellow for Vanderbilt's Breast SPORE during that year. After receiving her appointment as faculty in July 2004, she is now a member of the Surgical Pathology and Cytopathology faculty, in addition to being a member of the Breast Consultation Service. Research efforts include continued participation in the Breast SPORE efforts and specific areas of interest include ELUCA and Adenomyoepitheliomas.